Viral Immunology

Papers
(The TQCC of Viral Immunology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
The Impact of Vaccination on the Likelihood of COVID-19 Infection23
Does COVID-19 Vaccination with BNT162b2 Influence HIV-Related Immunological and Virological Markers? Data from 235 Persons Living with HIV at Cotugno Hospital, Naples, Italy: Immune Response After Sec22
Epidemiologic Characteristics of SARS-CoV-2 Omicron BA.5.1.3 Variant and the Protection Provided By Inactivated Vaccination20
Interleukin-4 Promotes Human Metapneumovirus Replication Through the JAK/STAT6 Pathway15
Investigating the Immunogenic Properties of a Mutagenized NS3/4A-Based HCV Genotype 3a DNA Vaccine14
Epstein-Barr Virus Antibodies and Autoimmune Diseases: A Bidirectional Mendelian Randomization Analysis14
Effect of Disease-Modifying Therapies on COVID-19 Vaccination Efficacy in Multiple Sclerosis Patients: A Comprehensive Review14
Human Endogenous Retroviruses and Toll-Like Receptors14
Evaluation of an Immunoglobulin E Capture Enzyme-Linked Immunosorbent Assay for the Early Diagnosis of Dengue14
Peripheral Circulating Exosomal-miRNAs Potentially Mediate the Sensitivity to Interferon Treatment in Chronic Hepatitis B Virus Patients13
Prevalence of SEN Virus-D and SEN Virus-H Among Hemodialysis Patients in Diyala Province13
Letter to the Editor: Should Viruses Exist? A Brief Reflection on the (Re)evolution of the Virus–Life Relationship12
Maintenance of Long-Term Effective Humoral Immune Response in Patients with COVID-19 with Homologous or Heterologous Booster Vaccines: A Retrospective Study11
Hybrid Immunity Against Severe Acute Respiratory Syndrome Coronavirus 211
Memory T Cells Subpopulations in a Cohort of COVID-19 Vaccinated or Recovered Subjects10
Interleukin-36gamma Mediates the In Vitro Activation of CD8 + T Cells from Patients Living with Chroni9
Immunoinformatics-Based Identification of the Conserved Immunogenic Peptides Targeting of Zika Virus Precursor Membrane Protein9
Plasma Levels of Secreted Cytokines in Virologically Controlled HIV-Infected Aging Adult Individuals on Long-Term Antiretroviral Therapy9
Clinical Significance of BTLA and HVEM Expression on Circulating CD4 + T and CD8 + T Cells in Chro9
Immunogenicity of a Candidate Live Attenuated Vaccine for Rift Valley Fever Virus with a Two-Segmented Genome9
No Evidence of Anti-Influenza Nucleoprotein Antibodies in Retail Milk from Across Canada (April–July 2024)8
Human Cytomegalovirus Infection and Cardiovascular Disease: Current Perspectives8
Measles and Rubella Seroprevalence Among Children and Adolescents of Córdoba, Argentina: A Cross-Section Study in the Context of the Elimination Program8
Acknowledgment of Reviewers 20247
Cross-Neutralization of Vanguard C4 Vaccine Against Australian Isolates of Canine Parvovirus Variants CPV-2a, CPV-2b, and CPV-2c7
Evaluation of an F Protein-Based Recombinant Protein for Immunization Against Respiratory Syncytial Virus7
Persistence of RNA Viruses in the Respiratory Tract: An Overview7
Virus-Induced Programmed Cell Death: To Die, or Not to Die?7
Expression of Concern: “Variations in the S and P Regions of the Hepatitis B Virus Genome Under Immunosuppression In Vitro and In 7
A Series of Articles About T Cells and Vaccines6
Differential Expression Patterns of Indoleamine 2,3-Dioxygenase 1 and Other Tryptophan and Arginine Catabolic Pathway Genes in Dengue Correlate with Clinical Severity-Pilot Study Results6
Acknowledgment of Reviewers 20236
Dengue Virus Increases the Expression of TREM-1 and CD10 on Human Neutrophils6
Clinical Characteristics and Immune Status of Patients with Severe Fever with Thrombocytopenia Syndrome6
The Potential of mRNA Vaccines to Fight Against Viruses6
Effective Treatment of COVID-19 Infection with Repurposed Drugs: Case Reports6
Knowledge on Human Papillomavirus Infections, Cancer Biology, Immune Interactions, Vaccination Coverage and Common Treatments: A Comprehensive Review5
Serological Markers and EBV DNA of Epstein–Barr Virus Infection in a Health Examination Cohort from Chongqing, China5
Hepatitis B Virus Envelope Antigen and Hepatitis B Virus Surface Antigen Both Contribute to the Innate Immune Response During Persistent Hepatitis B Virus Infection5
Comparison of Immunogenicity Between a Candidate Live Attenuated Vaccine and an Inactivated Vaccine for Cache Valley Virus5
Differential Reactivation of Cytomegalovirus and Epstein–Barr Virus in Patients with B Cell Lymphoma5
Cytokine Profile in Patients with Postacute Sequelae of COVID-195
Altered TLR7 Expression-Mediated Immune Modulation Is Supportive of Persistent Replication and Intrauterine Transmission of HBV5
Humoral and Cellular Immune Response to SARS-CoV-2 in Children Undergoing Cardiac Surgery4
Cross-Reactive Profile Against Two Conserved Coronavirus Antigens in Sera from SARS-CoV-2 Hybrid and Vaccinated Immune Donors4
Elevation of Myeloperoxidase Correlates with Disease Severity in Patients with Hantaan Virus Infection4
Expression Pattern of Cholesterol 25-Hydroxylase and Serum Level of 25-Hydroxycholesterol and Relevant Inflammatory Cytokines in Patients with Varying Disease Severity of COVID-194
Expression Pattern of Inflammatory and Anti-Inflammatory Cytokines and Key Differential Transcription Factors in Peripheral Blood Mononuclear Cells of Iranian Coronavirus Disease 2019 Patients with Di4
IGH Complementarity Determining Region-3-Cytomegalovirus Protein Chemical Complementarity Linked to Better Overall Survival Probabilities for Glioblastoma4
Correlation Between TWEAK Serum Level and HTLV-1 Proviral Load in HAM/TSP4
A Stable mRNA-Based Novel Multi-Epitope Vaccine Designs Against Infectious Heartland Virus by Integrated Immunoinformatics and Reverse Vaccinology Approaches4
Single-Cell and Mendelian Randomization Analyses Identify Key Genes Common to COVID-19 and Multiple Sclerosis4
Response to Daungsupawong/Wiwanitkit LTE4
The Nuclear Pore Complex 62 Suppression Inhibits Coxsackievirus B Replication and Inflammatory Response4
BK Virus Infection in Kidney Transplant Recipients: Genotypic Variations and Clinical Outcomes in Tehran, Iran (2018–2019)4
Intracellular Toll-Like Receptors Modulate Adaptive Immune Responses in Head and Neck Cancer4
Enhanced Programmed Cell Death Protein 1/Programmed Cell Death Ligand 1 Expression Induced by Severe Influenza A Virus Infection Impairs Host's Antiviral Response4
Advances in the Epidemiology, Pathogenesis, Diagnostic Methods, and Vaccine Development of Dengue Fever: A Comprehensive Review4
Immunogenic Response Assessment of Hepatitis Delta Virus Antigen from Pakistani Isolate in Rabbits Using a Prokaryotic Expression System4
The Role of Lymphocyte Subsets, PD-1, and FAS (CD95) in COVID-19 Cancer Patients4
Asymptomatic COVID-19 Reinfection in a Pediatric Patient with Heterotaxy Syndrome4
Investigation of the Seroprevalence of Antimeasles Immunoglobulin G Antibody in Students at Shiraz University of Medical Sciences4
The Age-Dependent Role of Th22, Tc22, and Tc17 Cells in the Severity of Pneumonia in COVID-19 Immunopathogenesis4
Characterization of Pre-Existing Neutralizing Antibody to Human Adenovirus Types 5 and 49 and Simian Type 23 in Chinese Population4
Production and Evaluation of Anti-Sera Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants Using a Syrian Hamster Model4
Correction to: A Seroprevalence Study on Residents in a Senior Care Facility with Breakthrough SARS-CoV-2 Omicron Infection, by Kim, et al. Viral Immunology 2023;36(3):203–4
0.084395885467529